Stream Link
7PM ET: https://event.arraylive.com/app/login/de16ae11-849e-44e4-94f7-23a2c260127e/virtualattendee
Program Description
Hyperglycemia is a common adverse effect of targeted PI3K and AKT inhibitors in breast cancer and requires a multidisciplinary approach to management. At this intersection of oncology and endocrinology, effective care requires the expertise of oncologists to manage the primary cancer treatment and pharmacists to navigate the nuanced drug interactions and select appropriate antihyperglycemic agents that do not compromise anticancer efficacy. In this panel discussion, experts will provide a concise review of risk factors and prevention strategies, providing a foundation for a deeper discussion on implementation and actionable, real-world solutions within care teams. The core of this program will be dedicated to pharmacist-led interventions, where panelists will share their experiences and successes in leveraging team-based care to prevent treatment-induced hyperglycemia. The discussion will cover crucial topics such as patient monitoring, the nuances of selecting appropriate antihyperglycemic therapies, and strategies for navigating the challenges of multidisciplinary management. By highlighting successful models, best practices, and protocols for monitoring and management, this panel will equip oncology pharmacists to take a leadership role in developing and implementing institutional guidelines, ultimately improving patient outcomes and continuity of care for those receiving PI3K and AKT inhibitor therapies.
Taylor Monson, PharmD, BCPS, BCOP
Clinical Oncology Pharmacist, Breast Oncology
Clinical Oncology Team Lead, Solid Tumors
The University of Kansas Health System
Kansas City, KS
Megan May, PharmD, BCOP
Oncology Clinical Pharmacy Specialist
Baptist Health Lexington
Lexington, KY
Jodi Taraba, PharmD, MSc, BCOP
Moderator
Breast Cancer Clinical Pharmacist
Assistant Professor of Pharmacy
Mayo Clinic
Rochester, MN
Accreditation
Accreditation Information
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
Each CE broadcast/symposium is approved for 1.0 contact hour (0.10 CEU) of application-based credit.
Obtaining Credit
All participants who attended the live virtual broadcast need to log on to their Pharmacy Times Continuing Education™ account on www.pharmacytimes.org to complete an online evaluation form and request their credit. Instructions on receiving credit will be provided the day of the event.